Market
Cytokinetics, Incorporated
Buy
Sell
One time
USD
CYTK
≈
0.12374706
CYTK
$50
$150
$500
Pay with
Google Pay
Apple Pay
USD Account
1-2 business days • No fees
Credit/debit card
Instant •
2.99%
0% fee first 30 days
| Time | Price | Change |
|---|---|---|
| Today | 0.00% | |
| 1 day | +$0.45 (0.66%) | |
| 1 week | -$2.79 (4.51%) | |
| 1 month | +$2.58 (2.05%) | |
| 1 year | +$3.86 (3.74%) |
CYTK
$80.81
-0.66%
Rank
#12655
All-time high
$90.00
-11.37%
All-time low
$66.21
18.07%
Cytokinetics is a biopharmaceutical company focused on cancer and cardiovascular disease treatment. Co.'s drug candidate, SB-715992, is a Phase II clinical trials program conducted by its partner GlaxoSmithKline and the National Cancer Institute.
Make investing stress-free
Trade with deep liquidity and low fees
